For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.

Elevance Health (ELV) came out with quarterly earnings of $11.97 per share, beating the Zacks Consensus Estimate of $11.21 per share. This compares to earnings of $10.64 per share a year ago.

Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best stocks that will always grow. Threats of an impending recession are looming over ...

Elevance Health Inc. spent less money on medical care than analysts expected in the first quarter, easing investor concerns after UnitedHealth Group Inc. reported ballooning costs. Elevance ...

Despite rising costs in its health plans, Elevance Health reported more than $2 billion in first quarter net income thanks to growth across its health plans and Carelon health services business.

Reports Q1 revenue $48.8B, consensus $46.25B. “At Elevance Health (ELV), our purpose-to improve the health of humanity-drives everything we do. In the first quarter, we made measurable progress ...

Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid ...

Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Tuesday reported first-quarter earnings of $2.18 billion. The Indianapolis-based company said it had profit of $9.61 per ...